|
• December 2. Innohep (tinzaparin): Clinical study stopped early because of interim finding of increased all-cause mortality in patients who received drug. Information
• December 2. FDA issues questions and answers on medication guides for erythropoiesis-stimulating agents (ESAs). Information
• November 24. Phenytoin and Fosphenytoin Sodium associated with potential increased risk of serious skin reactions. Information for Healthcare Professional
• November 18. CSI USA Inc. and FDA inform consumers and healthcare professionals of a nationwide recall of all lots of 1 ounce tubes of 10% Benzoyl Peroxide Acne Cream. MedWatch Safety Information
• November 12. FDA updates the Early Communication about the Ongoing Safety Review of Bisphosphonates. Information
Previous News Items
|
